<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>GLYCOPYRROLATE- glycopyrrolate tablet </strong><br>Qualitest Pharmaceuticals<br></p></div>
<h1>GLYCOPYRROLATE TABLETS, USP<br> 1 mg and 2 mg</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="LINK_59a985fb-75ba-4bd1-ba96-f4847f0d1a4e"></a><a name="section-1"></a><p></p>
<h1></h1>
<p class="First"><span class="Bold">Rx only</span></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="LINK_4b4534a2-fe14-46e4-9aee-ec4c443111bf"></a><a name="section-2"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Glycopyrrolate Tablets, USP contain the synthetic anticholinergic, glycopyrrolate. Glycopyrrolate is a quaternary ammonium compound with the following chemical name: 3-[(cyclopentylhydroxyphenylacetyl)oxy]-1, 1-dimethylpyrrolidinium bromide.</p>
<p>The structural formula of Glycopyrrolate is represented below:</p>
<div class="Figure"><img alt="This image is the structural formula for Glycopyrrolate." src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=a9fe52b4-9290-4e26-a142-1506572bc217&amp;name=glycopyrrolate-1.jpg"></div>
<p>Glycopyrrolate is supplied as 1 mg and 2 mg tablets.</p>
<div class="Section" data-sectionCode="51727-6">
<a name="LINK_26cdf98d-29b6-4418-9f54-9c86849f53ff"></a><a name="section-2.1"></a><p></p>
<h2>Inactive ingredients:</h2>
<p class="First">dibasic calcium phosphate, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and sodium starch glycolate</p>
</div>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="LINK_f50c7613-53f0-41cd-8219-db673dcaad14"></a><a name="section-3"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">Glycopyrrolate, like other anticholinergic (antimuscarinic) agents, inhibits the action of acetylcholine on structures innervated by postganglionic cholinergic nerves and on smooth muscles that respond to acetylcholine but lack cholinergic innervation. These peripheral cholinergic receptors are present in the autonomic effector cells of smooth muscle, cardiac muscle, the sino-atrial node, the atrioventricular node, exocrine glands, and, to a limited degree, in the autonomic ganglia. Thus, it diminishes the volume and free acidity of gastric secretions and controls excessive pharyngeal, tracheal, and bronchial secretions.</p>
<p>Glycopyrrolate antagonizes muscarinic symptoms (e.g., bronchorrhea, <span class="product-label-link" type="condition" conceptid="256717" conceptname="Bronchospasm">bronchospasm</span>, <span class="product-label-link" type="condition" conceptid="4169095" conceptname="Bradycardia">bradycardia</span>, and <span class="product-label-link" type="condition" conceptid="4010029" conceptname="Increased intestinal motility">intestinal hypermotility</span>) induced by cholinergic drugs such as the anticholinesterases.</p>
<p>The highly polar quaternary ammonium group of glycopyrrolate limits its passage across lipid membranes, such as the blood-brain barrier, in contrast to atropine sulfate and scopolamine hydrobromide, which are non-polar tertiary amines which penetrate lipid barriers easily.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="LINK_b752c8d7-59b2-4ec8-a075-757def96a636"></a><a name="section-4"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">For use as adjunctive therapy in the treatment of <span class="product-label-link" type="condition" conceptid="4027663" conceptname="Peptic ulcer">peptic ulcer</span>.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="LINK_bc80d5e4-e2ea-4297-a788-15fff7069aa3"></a><a name="section-5"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First"><span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">Glaucoma</span>; <span class="product-label-link" type="condition" conceptid="194406" conceptname="Urinary tract obstruction">obstructive uropathy</span> (for example, <span class="product-label-link" type="condition" conceptid="433813" conceptname="Bladder neck obstruction">bladder neck obstruction</span> due to <span class="product-label-link" type="condition" conceptid="198803" conceptname="Benign prostatic hyperplasia">prostatic hypertrophy</span>); obstructive disease of the gastrointestinal tract (as in achalasia, pyloroduodenal stenosis, etc.); <span class="product-label-link" type="condition" conceptid="192357" conceptname="Paralytic ileus">paralytic ileus</span>; intestinal atony of the elderly or debilitated patient; unstable cardiovascular status in acute <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">hemorrhage</span>; severe <span class="product-label-link" type="condition" conceptid="81893" conceptname="Ulcerative colitis">ulcerative colitis</span>; toxic <span class="product-label-link" type="condition" conceptid="198465" conceptname="Megacolon, not Hirschsprung's">megacolon</span> complicating <span class="product-label-link" type="condition" conceptid="81893" conceptname="Ulcerative colitis">ulcerative colitis</span>; <span class="product-label-link" type="condition" conceptid="76685" conceptname="Myasthenia gravis">myasthenia gravis</span>.  Glycopyrrolate tablets are contraindicated in those patients with a <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to glycopyrrolate.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="LINK_219ed6cb-f5c4-42f3-a1d3-30d58f4af974"></a><a name="section-6"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">In the presence of a high environmental temperature, <span class="product-label-link" type="condition" conceptid="437744" conceptname="Heat exhaustion">heat prostration</span> (<span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span> and <span class="product-label-link" type="condition" conceptid="4181404" conceptname="Heat stroke">heat stroke</span> due to decreased <span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">sweating</span>) can occur with use of glycopyrrolate tablets.</p>
<p><span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">Diarrhea</span> may be an early symptom of incomplete <span class="product-label-link" type="condition" conceptid="193518" conceptname="Intestinal obstruction">intestinal obstruction</span>, especially in patients with ileostomy or colostomy. In this instance treatment with this drug would be inappropriate and possibly harmful.</p>
<p>Glycopyrrolate tablets may produce <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span> or <span class="product-label-link" type="condition" conceptid="4079185" conceptname="Hazy vision">blurred vision</span>. In this event, the patient should be warned not to engage in activities requiring mental alertness such as operating a motor vehicle or other machinery, or performing hazardous work while taking this drug.</p>
<p>Theoretically, with overdosage, a curare-like action may occur, i.e., neuro-muscular blockade leading to <span class="product-label-link" type="condition" conceptid="79908" conceptname="Muscle weakness">muscular weakness</span> and possible <span class="product-label-link" type="condition" conceptid="440377" conceptname="Paralysis">paralysis</span>.</p>
<div class="Section" data-sectionCode="42228-7">
<a name="LINK_450501f0-4762-44a0-a895-22f382527b9e"></a><a name="section-6.1"></a><p></p>
<h2>Pregnancy</h2>
<p class="First">The safety of this drug during pregnancy has not been established. The use of any drug during pregnancy requires that the potential benefits of the drug be weighed against possible hazards to mother and child.  Reproduction studies in rats revealed no teratogenic effects from glycopyrrolate; however, the potent anticholinergic action of this agent resulted in diminished rates of conception and of survival at weaning, in a dose-related manner. Other studies in dogs suggest that this may be due to diminished seminal secretion which is evident at high doses of glycopyrrolate. Information on possible adverse effects in the pregnant female is limited to uncontrolled data derived from marketing experience. Such experience has revealed no reports of teratogenic or other fetus-damaging potential. No controlled studies to establish the safety of the drug in pregnancy have been performed.</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="LINK_c0640397-2048-448c-a025-3e91c7a8d5f5"></a><a name="section-6.2"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First">It is not known whether this drug is excreted in human milk. As a general rule, nursing should not be undertaken while a patient is on a drug since many drugs are excreted in human milk.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="LINK_19e35244-404d-40c8-aa9f-af6a212da7fa"></a><a name="section-6.3"></a><p></p>
<h2>Pediatric Use</h2>
<p class="First">Since there is no adequate experience in pediatric patients who have received this drug, safety and efficacy in pediatric patients have not been established.</p>
</div>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="LINK_3839fdc7-f4f9-4bb6-8697-4f74f56bb41c"></a><a name="section-7"></a><p></p>
<h1>PRECAUTIONS</h1>
<p class="First">Use glycopyrrolate tablets with caution in the elderly and in all patients with:</p>
<ul class="Disk">
<li><span class="product-label-link" type="condition" conceptid="4080146" conceptname="Autonomic neuropathy">Autonomic neuropathy</span>.</li>
<li>Hepatic or <span class="product-label-link" type="condition" conceptid="198124" conceptname="Kidney disease">renal disease</span>.</li>
<li><span class="product-label-link" type="condition" conceptid="81893" conceptname="Ulcerative colitis">Ulcerative colitis</span>-large doses may suppress intestinal motility to the point of producing a <span class="product-label-link" type="condition" conceptid="192357" conceptname="Paralytic ileus">paralytic ileus</span> and for this reason may precipitate or aggravate "toxic <span class="product-label-link" type="condition" conceptid="198465" conceptname="Megacolon, not Hirschsprung's">megacolon</span>," a serious complication of the disease.</li>
<li><span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">Hyperthyroidism</span>, coronary heart disease, <span class="product-label-link" type="condition" conceptid="319835" conceptname="Congestive heart failure">congestive heart failure</span>, cardiac <span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">tachyarrhythmias</span>, <span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">tachycardia</span>, <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span> and <span class="product-label-link" type="condition" conceptid="198803" conceptname="Benign prostatic hyperplasia">prostatic hypertrophy</span>.</li>
<li><span class="product-label-link" type="condition" conceptid="4224004" conceptname="Hiatal hernia">Hiatal hernia</span> associated with <span class="product-label-link" type="condition" conceptid="30437" conceptname="Gastro-esophageal reflux disease with esophagitis">reflux esophagitis</span>, since anticholinergic drugs may aggravate this condition.</li>
</ul>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="LINK_b62a5d16-8c51-43f6-b4e2-109d3334ec6a"></a><a name="section-8"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">Anticholinergics produce certain effects, most of which are extensions of their fundamental pharmacological actions. Adverse reactions to anticholinergics in general may include <span class="product-label-link" type="condition" conceptid="4226991" conceptname="Aptyalism">xerostomia</span>; decreased <span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">sweating</span>; <span class="product-label-link" type="condition" conceptid="201688" conceptname="Delay when starting to pass urine">urinary hesitancy</span> and retention; <span class="product-label-link" type="condition" conceptid="4079185" conceptname="Hazy vision">blurred vision</span>; <span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">tachycardia</span>; <span class="product-label-link" type="condition" conceptid="315078" conceptname="Palpitations">palpitations</span>; dilatation of the pupil; <span class="product-label-link" type="condition" conceptid="375263" conceptname="Cycloplegia">cycloplegia</span>; increased ocular <span class="product-label-link" type="condition" conceptid="4200706" conceptname="Tension">tension</span>; <span class="product-label-link" type="condition" conceptid="4289517" conceptname="Loss of taste">loss of taste</span>; <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headaches</span>; <span class="product-label-link" type="condition" conceptid="436817" conceptname="Feeling nervous">nervousness</span>; <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">mental confusion</span>; <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>; <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">weakness</span>; <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>; <span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">insomnia</span>; <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>; <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>; <span class="product-label-link" type="condition" conceptid="75860" conceptname="Constipation">constipation</span>; <span class="product-label-link" type="condition" conceptid="4218984" conceptname="Abdominal distension">bloated feeling</span>; <span class="product-label-link" type="condition" conceptid="4216771" conceptname="Impotence">impotence</span>; suppression of lactation; severe <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergic reaction</span> or drug idiosyncrasies including <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylaxis</span>, <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span> and other dermal manifestations.</p>
<p>Glycopyrrolate tablets are chemically quaternary ammonium compounds; hence, its passage across lipid membranes, such as the blood-brain barrier, is limited in contrast to atropine sulfate and scopolamine hydrobromide. For this reason the occurrence of CNS-related side effects is lower, in comparison to their incidence following administration of anticholinergics which are chemically tertiary amines that can cross this barrier readily.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="LINK_9dc69076-98fa-465b-aeb5-0a1424364380"></a><a name="section-9"></a><p></p>
<h1>OVERDOSAGE</h1>
<p class="First">The symptoms of overdosage of glycopyrrolate are peripheral in nature rather than central.</p>
<ol class="Arabic">
<li>To guard against further absorption of the drug–use gastric lavage, cathartics and/or enemas.</li>
<li>To combat peripheral anticholinergic effects (residual <span class="product-label-link" type="condition" conceptid="4290615" conceptname="Dilated pupil">mydriasis</span>, <span class="product-label-link" type="condition" conceptid="4226991" conceptname="Aptyalism">dry mouth</span>, etc.)–utilize a quaternary ammonium anticholinesterase, such as neostigmine methylsulfate.</li>
<li>To combat hypotension–use pressor amines (norepinephrine, metaraminol) i.v.; and supportive care.</li>
<li>To combat respiratory depression–administer oxygen; utilize a respiratory stimulant such as Dopram<span class="Sup">®</span> i.v.; artificial respiration.</li>
</ol>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="LINK_0ca381b6-7d79-40a1-b7a7-a539a55d510b"></a><a name="section-10"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First"><span class="Italics">The dosage of glycopyrrolate tablets 1 mg or 2 mg should be adjusted to the needs of the individual patient to assure symptomatic control with a minimum of adverse reactions. The presently recommended maximum daily dosage of glycopyrrolate is 8 mg.</span></p>
<p><span class="Bold">Glycopyrrolate tablets 1 mg.</span></p>
<p>The recommended initial dosage of glycopyrrolate tablets 1 mg for adults is one tablet three times daily (in the morning, early afternoon, and at bedtime). Some patients may require two tablets at bedtime to assure overnight control of symptoms. For maintenance, a dosage of one tablet twice a day is frequently adequate.</p>
<p><span class="Bold">Glycopyrrolate tablets 2 mg.</span></p>
<p>The recommended dosage of glycopyrrolate tablets 2 mg for adults is one tablet two or three times daily at equally spaced intervals.</p>
<p>Glycopyrrolate tablets are not recommended for use in pediatric patients under the age of 12 years.</p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="LINK_e4da3b93-9dab-416a-84c7-d4505ec9b619"></a><a name="section-11"></a><p></p>
<h1>DRUG INTERACTIONS</h1>
<p class="First">There are no known drug interactions.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="LINK_69fbca7d-90e2-41c4-8e12-f923e97b62c2"></a><a name="section-12"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">Glycopyrrolate Tablets, USP 1 mg are white, round, scored, flat-faced, beveled edge, debossed "3180" on one side and debossed "V" on the reverse side, supplied in bottles of 10, 100, and 1000.</p>
<p>Glycopyrrolate Tablets, USP 2 mg are white, round, scored, flat-faced, beveled edge, debossed "3181" on one side and debossed "V" on the reverse side, supplied in bottles of 10, 100, and 1000.</p>
<div class="Section" data-sectionCode="44425-7">
<a name="LINK_6b3d19ca-a6c7-4c64-a5e3-76223f2d7a38"></a><a name="section-12.1"></a><p></p>
<h2></h2>
<p class="First"><span class="Bold">Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].</span></p>
<p><span class="Bold">Dispense in tight container.</span></p>
</div>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="LINK_e2419565-05af-4ee6-b798-e2e691116ae1"></a><a name="section-13"></a><p></p>
<h1></h1>
<p class="First">Manufactured for:<br><span class="Bold">QUALITEST PHARMACEUTICALS<br></span>Huntsville, AL 35811</p>
<p>8182341<br>R12/08-R0</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="LINK_22422cac-ed99-4692-82dc-36ce0ee471bb"></a><a name="section-14"></a><p></p>
<h1><span class="Bold">PRINCIPAL DISPLAY PANEL</span></h1>
<div class="Figure"><img alt="This is an image of the Principal Display Panel for Glycopyrrolate 1 mg 100 Tablets." src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=a9fe52b4-9290-4e26-a142-1506572bc217&amp;name=glycopyrrolate-2.jpg"></div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="LINK_1f6a6557-6200-4c97-8b28-ab0e4e196da3"></a><a name="section-15"></a><p></p>
<h1><span class="Bold">PRINCIPAL DISPLAY PANEL</span></h1>
<div class="Figure"><img alt="This is an image of the Principal Display Panel for Glycopyrrolate 2 mg 100 Tablets." src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=a9fe52b4-9290-4e26-a142-1506572bc217&amp;name=glycopyrrolate-3.jpg"></div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>GLYCOPYRROLATE 		
					</strong><br><span class="contentTableReg">glycopyrrolate tablet</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0603-3180</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>GLYCOPYRROLATE</strong> (GLYCOPYRRONIUM) </td>
<td class="formItem">GLYCOPYRROLATE</td>
<td class="formItem">1 mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>LACTOSE MONOHYDRATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>MAGNESIUM STEARATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>CELLULOSE, MICROCRYSTALLINE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SODIUM STARCH GLYCOLATE TYPE A POTATO</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">WHITE</td>
<td class="formLabel">Score</td>
<td class="formItem">2 pieces</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">ROUND</td>
<td class="formLabel">Size</td>
<td class="formItem">7mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">3180;V</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0603-3180-10</td>
<td class="formItem">10  in 1 BOTTLE, PLASTIC; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:0603-3180-21</td>
<td class="formItem">100  in 1 BOTTLE, PLASTIC; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">3</th>
<td class="formItem">NDC:0603-3180-32</td>
<td class="formItem">1000  in 1 BOTTLE, PLASTIC; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA040821</td>
<td class="formItem">12/29/2008</td>
<td class="formItem">05/31/2017</td>
</tr>
</table></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>GLYCOPYRROLATE 		
					</strong><br><span class="contentTableReg">glycopyrrolate tablet</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0603-3181</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>GLYCOPYRROLATE</strong> (GLYCOPYRRONIUM) </td>
<td class="formItem">GLYCOPYRROLATE</td>
<td class="formItem">2 mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>LACTOSE MONOHYDRATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>MAGNESIUM STEARATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>CELLULOSE, MICROCRYSTALLINE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SODIUM STARCH GLYCOLATE TYPE A POTATO</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">WHITE</td>
<td class="formLabel">Score</td>
<td class="formItem">2 pieces</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">ROUND</td>
<td class="formLabel">Size</td>
<td class="formItem">9mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">3181;V</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0603-3181-10</td>
<td class="formItem">10  in 1 BOTTLE, PLASTIC; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:0603-3181-21</td>
<td class="formItem">100  in 1 BOTTLE, PLASTIC; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">3</th>
<td class="formItem">NDC:0603-3181-32</td>
<td class="formItem">1000  in 1 BOTTLE, PLASTIC; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA040821</td>
<td class="formItem">12/29/2008</td>
<td class="formItem">06/30/2017</td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Qualitest Pharmaceuticals
							(011103059)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Vintage Pharmaceuticals-Huntsville</td>
<td class="formItem"></td>
<td class="formItem">825839835</td>
<td class="formItem">MANUFACTURE(0603-3180, 0603-3181)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 10/2015<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>b26472f4-c0e2-44fa-b264-9b85d4061deb</div>
<div>Set id: a9fe52b4-9290-4e26-a142-1506572bc217</div>
<div>Version: 7</div>
<div>Effective Time: 20151002</div>
</div>
</div> <div class="DistributorName">Qualitest Pharmaceuticals</div></p>
</body></html>
